Skip to main content

The Impact of the Affordable Care Act on Cancer Prevention and Cancer Care: A Virtual Workshop

Completed

On March 1 and 2, 2021, the National Cancer Policy Forum convened a virtual workshop to examine the evidence base on how the Patient Protection and Affordable Care Act (ACA) has altered the landscape of cancer prevention and care delivery.

Description

A National Academies of Sciences, Engineering, and Medicine planning committee will organize and host a 1.5-day public workshop to examine the impact of the Patient Protection and Affordable Care Act (ACA) on cancer prevention and care (early detection, diagnosis, treatment, and survivorship). The workshop will feature invited presentations and panel discussions on topics that may include:

· The effects of ACA provisions such as:

o Coverage for certain preventive care services without patient cost sharing;

o Prohibition of exclusions for preexisting conditions;

o Coverage of children up to age 26 on a parent’s health insurance plan; and

o State-based Medicaid expansions.

· The impact of new organizational infrastructure (e.g., the Patient-Centered Outcomes Research Institute and Centers for Medicare and Medicaid Innovation), and their relevance to cancer research.

· The effects of payment reform demonstration projects (such as accountable care organizations and the oncology medical home pilot) on patient outcomes and the quality and efficiency of oncology care delivery; as well as the viability and sustainability of alternative payment models.

· Remaining evidence gaps and policy challenges and their impact on patients with cancer.

· Lessons learned from the design and implementation of the ACA that could inform future health care reform efforts.

The planning committee will develop the agenda for the workshop sessions, select and invite speakers and discussants, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.


Collaborators

Sponsors

American Association for Cancer Research

American Cancer Society

American College of Radiology

American Society of Clinical Oncology

Association of American Cancer Institutes

Association of Community Cancer Centers

Bristol Myers Squibb

Cancer Support Community

Centers for Disease Control and Prevention (CDC)

CEO Roundtable on Cancer

Flatiron Health

Merck

National Cancer Institute

National Comprehensive Cancer Network

National Patient Advocate Foundation

Novartis Oncology

Oncology Nursing Society

Pfizer Inc.

Sanofi

Society for Immunotherapy of Cancer

Staff

Erin Balogh

Lead

EBalogh@nas.edu

Sharyl Nass

Lead

SNass@nas.edu

Lori Brenig

LBrenig@nas.edu

Rachel Austin

RaAustin@nas.edu

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.